@FierceMedDev: ICYMI yesterday: Devicemakers like $MDT, $ABT and $JNJ hold a total of $95 billion offshore--and that's just the tip of the iceberg. Article | Follow @FierceMedDev
@VarunSaxena2: This just in: $MDT will not pursue shareholder complaints against officers, board of directors over Infuse marketing. Filings | Follow @VarunSaxena2
@MichaelGFierce: Mayo Clinic team successfully delivers small molecules to the brain past blood-brain barrier. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: "Hackathons" bring together med tech minds to brainstorm innovative solutions to unmet needs in developing countries. Story from Wired | Follow @EmilyWFierce
> Medtronic ($MDT) confirms media reports that it is buying Corventis, maker of a wireless patch that monitors the heart. Story
> The Asian Harmonization Working Party released a white paper on regulating medical device software. Story
> Pulsar Vascular received FDA IDE approval for the PulseRider aneurysm neck reconstruction device. Release
> Cohera Medical announced that the FDA advisory panel hearing for its TissuGlu surgical adhesive will take place on Aug. 1. Release
Biotech News
@FierceBiotech: Can Orexigen and its partner Takeda escape the weight-drug jinx? Editor's corner | Follow @FierceBiotech
@JohnCFierce: Still trending: Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide. Article | Follow @JohnCFierce
@DamianFierce: Theme in $AGN's new slides: $VRX's big rush to do a deal is wild suspicious. More | Follow @DamianFierce
@EmilyMFierce: Compound could delay onset of Type 2 diabetes. FierceBiotech Research story | Follow @EmilyMFierce
> Allergan says no to $53B as Valeant gets hostile. Item
> Receptos shares spike as oral drug reduces brain lesions in PhII MS trial. More
> Dutch biotech arGEN-X plots an IPO as it pads its list of partners. Report
> Analysis: Idenix bidding was competitive, driving up the deal value for an eager Merck. Article
Pharma News
@FiercePharma: Top-read special report Monday: The top 10 pharma companies by 2013 revenue. Feature | Follow @FiercePharma
@TracyStaton: Would you pay $84K for Sovaldi yourself if you had hep C? Check out this discussion. | Follow @TracyStaton
@EricPFierce: New FDA warning letter says Alabama compounder is making sterile drugs in unsanitary facility. More | Follow @EricPFierce
@CarlyHFierce: Allergan spurns Valeant again, but shareholders may have other ideas. Article | Follow @CarlyHFierce
@JustinHFierce: After 7mil US pig deaths from PEDv, Tokyo announces outbreak guidelines on concerns of health-conscious Chinese. Story | Follow @JustinHFierce
> MS docs, activists pressure U.K. cost watchdog to bless Biogen, GW meds. More
> Japanese companies follow Sanofi's lead in shunning Big Pharma M&A trend. Report
> Shaky Dendreon loses its CEO as debt payments loom. News
Pharma Manufacturing News
> FDA says compounder making drugs under unsanitary conditions. More
> Drugmaker will use MIT 3-D printing process to make fast-melting capsules. Item
> More consolidation in the API market as Provence picks up peptidemaker Synprosis. Report
> Illinois man pleads guilty to selling $3M worth of foreign Botox. Story
> Roche's Avastin and MabThera are added to list of those stolen in Italy. Article
> Dr. Reddy's avoids pitfalls of Ranbaxy, Wockhardt by cutting workers out of production. More
Biotech Research News
> Compound could delay onset of Type 2 diabetes. Story
> ImStem therapy reverses multiple sclerosis symptoms in mice. More
> Levels of small molecule in brain may indicate depression. Article
> Report: $4.5B needed for BRAIN project through 2025. Item
> Stem cells transplanted successfully in pigs. Story